REG-PolyFuel Inc. Final Results - Part 1

Released: 06/05/2009

  com:20090506:RnsF7348R
                                                                                                                       .
RNS Number : 7348R  
  
PolyFuel Inc.  
  
06 May 2009  
  
06 May 2009  
  
POLYFUEL, INC.  
  
SURPASSES LITHIUM ION BATTERIES IN RUNTIME VERSUS SIZE AND WEIGHT  
  
AND ANNOUNCES PRELIMINARY RESULTS FOR  
  
12 MONTHS ENDED 31 DECEMBER 2008  
  
PolyFuel, Inc. (AIM: PYF) ("PolyFuel" or the "Company"), a world leader in fuel 
cell membrane products and related technologies, today announces the achievement 
of a key milestone in its Non-Stop Power reference design programme, a Direct 
Methanol Fuel Cell (DMFC) system which surpasses a lithium ion equivalent 
battery, a major industry technological achievement. The Company also announces 
its preliminary results for the year ended 31 December 2008.   
  
During the year, PolyFuel continued to develop its third generation DM3 membrane 
and novel Membrane Electrode Assembly (MEA), which together enable a significant 
simplification in customers' fuel cell system designs and the delivery of 
non-stop power for end users.  PolyFuel resolved several key technical 
challenges and has now achieved the 5th of 5 key milestones, in its cost-shared 
DOE programme, defined as completing a working demonstration prototype of a fuel 
cell power supply that achieves the small consumer-acceptable form factor 
necessary to integrate with a notebook PC and surpasses the performance of 
today's lithium-ion batteries in terms of runtime versus size and weight.   
  
Specifically, PolyFuel achieved this milestone by increasing the power output of 
the fuel cell, improving the thermal management of the system, improving the 
capacity of the fuel cartridge, and fine tuning the properties of the MEA to 
achieve the correct amount of water recycling. The industry-defined performance 
target for the fuel cell power supply was 10 hours of runtime at 15 watts 
average power in a 500cc integrated package, equating to an energy density of 
300 watt-hours per liter. PolyFuel's unit was able to easily surpass this, 
delivering 313 watt-hours per liter, at a 30% weight saving compared to any of 
today's equivalent lithium-ion battery packs.  
  
2008 Financial Highlights:  
  
 
 *      Generated revenue of US$2.0 million, an increase of US$0.6 million over 
2007 revenue of 
     US$1.4 million, the majority of which was from the Company's ATP program, 
DOE program, 
     and the US Army CERDEC program; 
 *      Net loss for the year was US$(7.6) million, an improvement of US$0.9 
million from a US$(8.5) 
     million loss in 2007; 
 *      Reduced overall expenditure levels to significantly lower the Company's 
cash burn rate (2009 
     cash burn rate is currently expected to average in the US$425,000 to 
US$450,000 per month 
     range, down from an average of approximately US$600,000 per month in 2008); 
and 
 *      Finished 2008 with US$6.6 million in cash and cash equivalents.  
  
Jim Balcom, Chief Executive Officer commented:  
  
"2008 was a challenging year for fuel cell technology in general, for the 
application of fuel cell technology to portable electronics in particular, and 
for PolyFuel. The development of portable fuel cell systems technology did not 
progress as quickly as we had expected. However, despite the slow progress on 
the commercialization front, the demand on behalf of consumers for longer 
runtime power supplies continues to grow.  Major consumer electronics companies 
and battery manufacturers continue to invest in portable fuel cell technology 
development, and particularly in direct methanol fuel cell technology.  PolyFuel 
continues to be recognized as a world leader in this field.  
  
PolyFuel has continued to advance the state of the art in DMFC with the 
announcement today that its prototype has surpassed lithium-ion batteries in 
terms of runtime versus size and weight.  We were also encouraged by the DOE's 
announcement two weeks ago that PolyFuel was awarded a grant of $2.5 million to 
further miniaturize the Company's Non-Stop Power reference design technology and 
to extend its durability and reduce its cost for broader commercial application. 
On the customer front we have signed Memoranda of Understanding with two large 
consumer electronics manufacturers for use of our Non-Stop Power technology and 
are working to progress those to joint development agreements for the 
introduction of fuel cell powered consumer products.  
  
We continue to seek additional capital to extend the Company's runway, which 
will be necessary to achieve the Company's objectives. "   
  
PolyFuel anticipates receiving an unqualified opinion from its auditors, 
PriceWaterhouseCoopers, regarding the Company's 2008 financial statements.  The 
PWC opinion, which will appear in PolyFuel's 2008 Annual Report, is also 
expected to include an explanatory paragraph with regard to the Company's 
ability to continue as a going concern.  
  
For further information, please contact:   
  
 
  PolyFuel, Inc.                                 Tel: +1 650 429 4646       
  Jim Balcom, Chief Executive Officer                                       
  Hogarth Partnership Limited                    Tel:  +44 (0)20 7357 9477  
  Nick Denton / Ian Payne                                                   
  KBC Peel Hunt (Nominated Adviser and Broker)   Tel:  +44 (0)20 7418 8900  
  Jonathan Marren / David Anderson                                          
  
  
About PolyFuel   
  
PolyFuel (www.polyfuel.com) is a world leader in fuel cell technology, 
particularly engineered membranes that provide significantly improved 
performance in both direct methanol and hydrogen fuel cells, especially for 
portable electronic and automotive applications. The state of the art of fuel 
cells is closely tied to the membrane, and PolyFuel's best in class, 
hydrocarbon-based membranes, enable a new generation of fuel cells that for the 
first time can deliver on the long-awaited promise of clean, long-running, and 
cost-effective portable power.  PolyFuel was spun out of SRI International 
(formerly the Stanford Research Institute) in 1999, after 14 years of applied 
membrane research. The company is based in Mountain View, California, and is 
publicly listed on the AIM stock exchange in London.   
  
Chairman and Chief Executive's Review  
  
2008 was a challenging year for fuel cell technology in general, for the 
application of fuel cell technology to portable electronics in particular, and 
for PolyFuel.   
  
The development of portable fuel cell systems technology did not progress as 
quickly as PolyFuel had expected.  However, during the year PolyFuel continued 
to develop its third generation DM3 membrane and novel membrane electrode 
assembly (MEA), which together will enable a significant simplification in 
customers' fuel cell system designs and the delivery of non-stop power for end 
users. These breakthroughs have been developed with the assistance of a $3 
million grant from the US Department of Energy.   PolyFuel solved several key 
challenges along the way to successfully reaching the 5th of five milestones in 
the program, defined as completing a working demonstration prototype of a fuel 
cell power supply that achieves the small consumer-acceptable form factor 
necessary to integrate with a notebook PC.   
  
Specifically, the achievement of this milestone included increasing the power 
output of the fuel cell, improving the thermal management of the system, 
improving the capacity of the fuel cartridge, and fine tuning the properties of 
the MEA to achieve the correct amount of water recycling. The specific 
performance target for the fuel cell power supply was 10 hours of runtime at 15 
watts average power in a 500cc integrated package, equating to an energy density 
of 300 watt-hours per liter. The Company's prototype system was able to easily 
surpass this, delivering an energy density of 313 watt-hours per liter, at a 30% 
weight saving compared to any of today's lithium-ion battery packs.  
  
PolyFuel is in discussions with several major notebook PC and Lithium ion 
battery manufacturers to secure one or more agreements for joint development of 
preproduction prototype systems for consumer electronic applications.  These 
agreements, which are expected to include a license to PolyFuel's non-membrane 
DM3 technology and long term supply agreement for PolyFuel's DM3 membrane, 
should accelerate commercialization of the partners'  fuel cell powered 
products.  Two of the targeted partners have signed MOUs confirming their 
intentions to complete negotiations with PolyFuel on the joint development 
agreements.    
  
In 2008, PolyFuel was awarded a continuation of its funded program with the US 
Army's Communications, Electronics Research and Development and Engineering 
Command (CERDEC).  The program is conducted in partnership with the University 
of North Florida and is expected to contribute approximately $450,000 in funding 
to PolyFuel during 2009.  The program goal is to ruggedize the Company's 
demonstration prototype system based on its breakthrough DM3 membrane and MEA 
technology.  
  
In April 2009, the Company received news from the US Department of Energy that 
it had been awarded a US$2.5 million grant under the American Recovery and 
Reinvestment Act.  The objectives of the program are to advance the Company's 
Non-Stop Power technology to achieve the durability targets required for 
commercialization, to further decrease the size of its demonstration prototype 
system, and to conduct design for manufacturability and assembly analyses along 
with its consumer electronics partners to achieve commercial cost targets.  
  
PolyFuel encountered difficulty with the commercial introduction of its second 
generation DM2 membrane.  The new DM2 membrane introduced in 2008 is designed to 
be a drop-in replacement for DuPont's more long-established Nafion membrane for 
customers that had already designed their prototype systems to accommodate the 
Nafion material.  During the development effort, customers had expressed a clear 
preference for the properties of PolyFuel's DM2 membrane compared to Nafion.  
However, the introduction of PolyFuel's DM2 membrane was delayed due to 
integration problems during customer qualification trials.  The Company invested 
significant time and effort in 2008 and early 2009 to identify and correct the 
cause of these problems and qualification trials of the DM2 membrane have 
recently been resumed with selected customers.  
  
During 2008 and into 2009 the Company implemented a number of cost saving 
measures.  Its monthly cash burn rate is currently expected to average 
approximately US$425,000-$450,000 in 2009, down from an average of approximately 
US$600,000 in 2008.   
  
PolyFuel finished 2008 with US$6.6 million in cash and cash equivalents. The 
Company has begun an aggressive program to secure additional sources of capital 
to help fund the completion of the Company's technology and product development 
and achieve commercial introduction, a process which is continuing in 2009.  
  
Fuel cell technology remains a challenging field, characterized by deep 
multidisciplinary science, significant technical hurdles, and a need for 
regulatory and infrastructure changes.  2008 saw a further key step in the 
worldwide implementation of new transportation regulations enabling portable 
fuel cells to be carried on board and operated on commercial aircraft and all 
other forms of commercial transportation.  The implementation of such 
regulations has been progressing strongly since before 2004, and all necessary 
directives related to the transport of direct methanol fuel cells and methanol 
fuel cartridges are now in place, enabling fuel cell powered portable electronic 
devices to become a commercial reality.    
  
Despite the slow progress on the commercialization front, the demand on behalf 
of consumers for longer runtime power supplies continues to grow.  Major 
consumer electronics companies and battery manufacturers continue to invest in 
portable fuel cell technology development, and particularly in direct methanol 
fuel cell technology.  PolyFuel continues to be recognized as one of the world 
leaders in this field.  
  
PolyFuel, Inc.  
  
(A development stage enterprise)  
  
UNAUDITED Consolidated Statements of Operations   
  
 
                                                                                                             Period from      
                                                                                                             27 January 1999  
                                                                                                             (Inception) to   
                                                 Year Ended 31 December                                      31 December      
                                                 2008                 2007                 2006              2008             
                                                 U.S.$                U.S.$                U.S.$             U.S.$            
                                                                                                                              
  Revenues                                       2,012,402            1,391,247            184,600           5,473,457        
                                                                                                                              
  Costs and operating expenses                                                                                                
  Research and development                       5,431,751            5,665,354            5,582,924         40,731,751       
  General and administrative                     4,457,005            5,099,380            5,433,608         34,266,612       
  Total expenses                                 9,888,756            10,764,734           11,016,532        74,998,363       
                                                                                                                              
  Loss from operations                           (7,876,354)          (9,373,487)          (10,831,932)      (69,524,906)     
                                                                                                                              
  Other income (expense), net                    (26,933)             (4,688)              (12,865)          (61,048)         
  Interest income                                292,771              921,176              1,230,979         3,405,066        
  Interest expense                               (586)                (635)                (59,863)          (1,591,912)      
                                                                                                                              
  Net loss                                       (7,611,102)          (8,457,634)          (9,673,681)       (67,772,800)     
                                                                                                                              
                                                                                                                              
  Net loss attributable to common stockholders   (7,611,102)          (8,457,634)          (9,673,681)       (55,557,688)     
                                                                                                                              
  Net loss per share                                                                                                          
  Basic                                          (0.13)               (0.15)               (0.17)                             
                                                 (0.13)               (0.15)               (0.17)                             
                                                                                                                              
  Weighted average number of shares used                                                                                      
  in net loss per share calculations                                                                                          
  Basic                                          57,811,388           57,368,049           56,154,107                         
  Diluted                                        57,811,388           57,368,049           56,154,107                         
  
  
PolyFuel, Inc.  
  
(A development stage enterprise)  
  
UNAUDITED Consolidated Balance Sheets   
  
 
                                                               31 December                                           
                                                               2008                2007                2006          
                                                               U.S.$               U.S.$               U.S.$         
  Assets                                                                                                             
                                                                                                                     
  Current assets                                                                                                     
  Cash and cash equivalents                                    6,574,138           7,126,685           15,177,509    
  Short-term investments                                       --                  6,576,170           6,654,886     
  Accounts receivable                                          197,782             134,511             35,434        
  Inventories                                                  15,021              114,192             88,806        
  Prepaid expenses and other current assets                    486,104             330,392             357,435       
  Total current assets                                         7,273,045           14,281,950          22,314,070    
                                                                                                                     
                                                                                                                     
  Property and equipment, net                                  366,977             337,039             460,405       
  Other assets                                                 23,556              195,300             195,300       
                                                                                                                     
  Total assets                                                 7,663,578           14,814,289          22,969,775    
                                                                                                                     
                                                                                                                     
  Liabilities and Stockholders' Equity                                                                               
                                                                                                                     
  Current liabilities                                                                                                
  Accounts payable and accrued expenses                        813,690             922,629             1,162,994     
  Deferred revenue                                             --                  1,336               115,475       
  Total current liabilities                                    813,690             923,965             1,278,469     
                                                                                                                     
                                                                                                                     
  Total liabilities                                            813,690             923,965             1,278,469     
                                                                                                                     
                                                                                                                     
  Stockholders' equity                                                                                               
  Common stock: US$0.001 par value; 100,000,000,                                                                     
  100,000,000 and 70,000,000 shares authorised at                                                                    
  31 December 2008, 2007 and 2006, respectively; 57,886,388,                                                         
  57,436,388,and 57,282,839 shares issued and outstanding at                                                         
  31 December 2008, 2007 and 200, respectively                 57,886              57,436              57,283        
  Additional paid-in capital                                   59,844,118          59,272,722          58,616,546    
  Accumulated other comprehensive income                       --                  1,180               857           
  Deficit accumulated during development stage                 (53,052,116)        (45,441,014)        (36,983,380)  
  Total stockholders' equity                                   6,849,888           13,890,324          21,691,306    
                                                                                                                     
  Total liabilities and stockholders' equity                   7,663,578           14,814,289          22,969,775    
  
  
PolyFuel, Inc.  
  
(A development stage enterprise)  
  
UNAUDITED Consolidated Statements of   
  
stockholders'EQUITY (deficit)   
  
 
                                                                                                                                                           Deficit                            
                                                                                                                            Notes          Accumulated     Accumulated       Total            
                                                                                                               Additional   Receivable     Other           During the        Stockholders     
                                                                                                               Paid-in      from           Comprehensive   Development       Equity           
                                                             Common Stock                                      Capital      Stockholders   Income          Stage    (Deficit)                 
                                                             Shares                                U.S.$       U.S.$        U.S.$          U.S.$           U.S.$             U.S.$            
                                                                                                                                                                                              
  Issuance of common stock for cash at US$25 per share                                                                                                                                        
  in January 1999                                            4                                     --          100          --             --              --                100              
  Net loss                                                   --                                    --          --           --             --              (59,926)          (59,926)         
  Balances at 31 December 1999                               4                                     --          100          --             --              (59,926)          (59,826)         
                                                                                                                                                                                              
  Issuance of common stock for in-process research and                                                                                                                                        
  development and notes payable in October 2000              9,120                                 9           205,191      --             --              --                205,200          
  Net loss                                                   --                                    --          --           --             --              (4,316,346)       (4,316,346)      
  Balances at 31 December 2000                               9,124                                 9           205,291      --             --              (4,376,272)       (4,170,972)      
                                                                                                                                                                                              
  Issuance of warrants with credit line and lease line                                                                                                                                        
  in May and July 2001                                       --                                    --          93,986       --             --              --                93,986           
  Exercise of common stock options at US$22.50 per share                                                                                                                                      
  for cash and notes receivable in May and December 2001     5,707                                 6           128,394      (127,116)      --              --                1,284            
  Stock based compensation expense                           --                                    --          5,954        --             --              --                5,954            
  Interest accrued on notes receivable                       --                                    --          --           (4,907)        --              --                (4,907)          
  Net loss                                                   --                                    --          --           --             --              (4,839,193)       (4,839,193)      
  Balances at 31 December 2001                               14,831                                15          433,625      (132,023)      --              (9,215,465)       (8,913,848)      
                                                                                                                                                                                              
  Issuance of warrants with lease line in June 2002          --                                    --          45,175       --             --              --                45,175           
  Exercise of common stock options at US$22.50 per share for cash                          64      --          1,438        --             --              --                1,438            
  Stock based compensation expense                           --                                    --          23,207       --             --              --                23,207           
  Cancellation of notes receivable                           --                                    --          --           44,438         --              --                44,438           
  Interest accrued on notes receivable                       --                                    --          --           (3,131)        --              --                (3,131)          
  Repurchase of common stock at US$4.50 per share                                                                                                                                             
  for notes receivable                                       (2,224)                               (2)         (10,008)     10,010         --              --                --               
  Net loss                                                   --                                    --          --           --             --              (7,017,090)       (7,017,090)      
  Balances at 31 December 2002                               12,671                                13          493,437      (80,706)       --              (16,232,555)      (15,819,811)     
                                                                                                                                                                                              
  Issuance of warrants with consulting agreement                                                                                                                                              
  in August and December 2003                                --                                    --          44,571       --             --              --                44,571           
  Issuance of warrants with finance facility in September    --                                    --          44,944       --             --              --                44,944           
  2003                                                                                                                                                                                        
  Exercise of common stock options at US$22.50 and                                                                                                                                            
  US$4.50 per share for cash                                 1,467                                 1           7,733        --             --              --                7,734            
  Cancellation of notes receivable                           --                                    --          --           34,469         --              --                34,469           
  Interest accrued on notes receivable                       --                                    --          --           (6,384)        --              --                (6,384)          
  Repurchase of common stock at US$4.50 per share                                                                                                                                             
  for notes receivable                                       (1,067)                               (1)         (4,799)      4,800          --              --                --               
  Net loss                                                   --                                    --          --           --             --              (8,887,814)       (8,887,814)      
  Balances at 31 December 2003                               13,071                                13          585,886      (47,821)       --              (25,120,369)      (24,582,291)     
                                                                                                                                                                                              
  Conversion of Series A1, A2 and B redeemable convertible                                                                                                                                    
  preferred stock in common stock and Series AA redeemable                                                                                                                                    
  convertible preferred stock upon recapitalisation          83,988                                84          6,022,301    --             --              14,720,684        20,743,069       
  Repurchase of common stock at US$22.50 per share                                                                                                                                            
  for notes receivable                                       (1,891)                               (2)         (186)        47,821         --              --                47,633           
  Issuance of warrants with finance facility in May 2004     --                                    --          174,150      --             --              --                174,150          
  Issuance of warrants with bridge loans in February and     --                                    --          533,957      --             --              --                533,957          
  April 2004                                                                                                                                                                                  
  Exercise of common stock options at US$0.10 per share for  2,833                                 3           280          --             --              --                283              
  cash                                                                                                                                                                                        
  Net loss                                                   --                                    --          --           --             --              (8,966,989)       (8,966,989)      
  Balances at 31 December 2004                               98,001                                98          7,316,388    --             --              (19,366,674)      (12,050,188)     
                                                                                                                                                                                              
  Issuance of warrants with consulting agreement in May      --                                    --          69,618       --             --              --                69,618           
  2005                                                                                                                                                                                        
  Conversion of Series AA and BB redeemable convertible                                                                                                                                       
  preferred stock into common stock upon admission to AIM    28,655,645                            28,656      22,608,911   --             --              --                22,637,567       
  Issuance of common stock and Series A Warrants for cash                                                                                                                                     
  at US$0.90 per unit in connection with initial public                                                                                                                                       
  offering                                                                                                                                                                                    
  in July 2005, net of issuance costs of US$2,767,027        15,686,276                            15,686      11,217,287   --             --              --                11,232,973       
  Issuance of common stock options to financial advisor                                                                                                                                       
  in connection with AIM Listing                             --                                    --          242,568      --             --              --                242,568          
  Stock-based compensation expense                           --                                    --          16,726       --             --              --                16,726           
  Exercise of common stock options at US$0.90 and                                                                                                                                             
  US$0.10 per share for cash                                 110,171                               110         11,740       --             --              --                11,850           
  Net loss                                                   --                                    --          --           --                             (7,943,025)       (7,943,025)      
                                                                                                                                                                                              
  
  
 
  Balances at 31 December 2005                             44,550,093   44,550   41,483,238   --   --        (27,309,699)   14,218,089   
  Issuance of common stock for cash at US$1.4052 per                                                                                     
  share in connection with follow-on offering in January                                                                                 
  2006, net of issuance costs of US$816,653                12,500,000   12,500   16,736,850   --   --        --             16,749,350   
  Stock-based compensation expense                         --           --       373,417      --   --        --             373,417      
  Comprehensive income - change in unrealised gain on                                                                                    
  available-for-sale investments                           --           --       --           --   857       --             857          
  Exercise of common stock options at US$0.10 per share    232,746      233      23,041       --   --        --             23,274       
  for cash                                                                                                                               
  Net loss                                                 --           --       --           --             (9,673,681)    (9,673,681)  
                                                                                                                                         
  Balances at 31 December 2006                             57,282,839   57,283   58,616,546   --   857       (36,983,380)   21,691,306   
  Stock-based compensation expense                         --           --       640,975      --   --        --             640,975      
  Comprehensive income - change in unrealised gain on                                                                                    
  available-for-sale investments                           --           --       --           --   323       --             323          
  Exercise of common stock options at US$0.10 per share    153,549      153      15,201       --   --        --             15,354       
  for cash                                                                                                                               
  Net loss                                                 --           --       --           --             (8,457,634)    (8,457,634)  
  Balances at 31 December 2007                             57,436,388   57,436   59,272,722   -    1,180     (45,441,014)   13,890,324   
                                                                                                                                         
  Stock-based compensation expense                         --           --       526,846      --   --        --             526,846      
  Comprehensive income - change in unrealised loss on                                                                                    
  available-for-sale investments                           --           --       --           --   (1,180)   --             (1,180)      
  Exercise of common stock options at US$0.10 per share    450,000      450      44,550       --   --        --             45,000       
  for cash                                                                                                                               
  Net loss                                                 --           --       --           --             (7,611,102)    (7,611,102)  
  Balances at 31 December 2008                             57,886,388   57,886   59,844,118   -    --        (53,052,116)   6,849,888    
  
  
PolyFuel, Inc.  
  
(A development stage enterprise)  
  
UNAUDITED Consolidated Statements of Cash Flows   
  
 
                                                                                                                 Period from                   
                                                                                                                 27 January 1999               
                                                                                                                 (Inception) to                
                                                           Year Ended 31 December                                31 December                   
                                                           2008                   2007                   2006                    2008          
                                                           U.S.$                  U.S.$                  U.S.$                   U.S.$         
  Cash flows from operating activities                                                                                                         
  Net loss                                                 (7,611,102)            (8,457,634)            (9,673,681)             (67,772,800)  
  Adjustments to reconcile net loss to net cash used in                                                                                        
  operating activities:                                                                                                                        
  Depreciation and amortisation                            186,596                221,863                338,217                 3,345,190     
  Purchased research and development                       --                     --                     --                      3,825,984     
  Stock-based expense - non-employees                      --                     --                     --                      45,887        
  Stock-based employee compensation expense                526,846                640,975                373,417                 1,541,238     
  Realized gain on sale of investments                     (9,907)                --                     --                      (9,907)       
  Provision for excess and obsolete inventory              2,313                  --                     --                      2,313         
  Loss (Gain) on sale of equipment                         6,990                  4,058                  --                      (105,677)     
  Non-cash expense related to notes receivable                                                                                                 
  from stockholders                                        --                     --                     --                      112,118       
  Non-cash expense related to issuance of warrants         --                     --                     --                      1,006,401     
  Non-cash interest expense related to bridge loans        --                     --                     --                      34,980        
  Changes in assets and liabilities:                                                                                                           
  Accounts receivable                                      (63,271)               (99,077)               (4,634)                 (197,782)     
  Inventories                                              96,858                 (25,384)               (88,806)                (17,334)      
  Prepaid expenses and other current assets                19,288                 27,043                 1,215                   (311,104)     
  Other assets                                             (3,257)                --                     (112,701)               (198,557)     
  Accounts payable and accrued expenses                    (108,939)              (240,366)              317,623                 1,036,722     
  Deferred revenue                                         (1,336)                (114,139)              115,475                 --            
                                                                                                                                               
  Net cash used in operating activities                    (6,958,921)            (8,042,661)            (8,733,875)             (57,662,328)  
                                                                                                                                               
  Cash flows from investing activities                                                                                                         
  Purchases of available for sale investments              (3,701,253)            (6,083,465)            (8,620,502)             (26,923,926)  
  Maturities and sales of available for sale investments   10,286,151             6,162,503              3,064,404               26,933,833    
  Proceeds from sale of property and equipment             12,651                 255                    --                      153,631       
  Purchase of property and equipment                       (236,175)              (102,810)              (182,858)               (3,760,121)   
                                                                                                                                               
  Net cash provided by (used in) investing activities      6,361,374              (23,517)               (5,738,956)             (3,596,583)   
                                                                                                                                                
  
  
More to follow, for following part double-click [nRn2F7348R]
 

Close Window